Case Series

Restenosis of Coronary Arteries in Patients with Coronavirus Infection: Case Series

Table 2

Laboratory indicators characterizing the presence of recurrent stent thrombosis in persons who underwent CVI.

Case nos.IgM <2IgG <10LEU (3.4–10.0NEUT (39.0–75.0)LYM (17.0–48.0)PLT (150–375)D-dimer(0.0–550.0)Troponin (0.008–0.029)CK (32.0–294.0)CK-МВ (0.0–25.0)Fibrinogen (2.0–3.93)Tg (0.34–1.7)LDL-beta(0.10–3.0)HDL alpha (1.0–2.60)

Persons with restenosis who underwent CVI (studied group)
10.503007.375.322.91554181.43218941.54.182.312.880.93
20.1287.56.874.322.52824890.34204263.92.512.761.2
30.7594.1814.480.618.15461411.04.8547146.18.071.322.560.95
43.128.217.280.28.4134432038.022121.0231.76.21.452.891.01
50.2137.2313.2064.833.0255799.940.02413.0380.82.853.932.791.06
60.6552.157.866.722.1349361.839.0631196.0120.94.321.542.990.9
72.77128.312.678.020.5243434.76.03010021.45.441.432.181.08
80.2876.669.157.939.3154492.50.05272213.641.982.181.12
90.4886.439.257.939.52032163.09419530.73.531.722.821.06
100.1896.27.874.320.1183.4192.00.031234.024.86.71.663.540.91

Persons with restenosis without CVI (comparison group)
110.114.1511.776.221.9209980.00.694569.94.41.932.230.83
120.162.5911.478.520.22521750.00457203.531.41.91.01
130.68.3311.588.28.41914324048446.94.181.83.681.1
140.84.86.8539.744.62794360.00298183.71.040.790.98
150.330.8218.665.931.92232153401612816122.32.342.40.97
161.16.414.879122164805.99668703.91.362.221.01
170.864.813.288.15.51852803.231070802.31.13.10.5
180.987.868.176.816.721480014.9863693.41.32.271.31
190.886.96.758.130.12399701.217272152.41.23.680.39
201.66.988.9157.534.31792560.00580372.75.533.70.69
0.436<0.0010.7960.7390.5290.9711.00.6040.7391.00.0190.1900.8530.684

LEU-leucocyte;NEUT-neutrophils;LYM-lymphocyte;PLT-thrombocyte;CK-creatine kinase; CK-МВ-creatine kinase MB; Tg-triglycerides; LDL-beta-low-density lipoprotein-beta; HDL alpha-high-density lipoprotein alpha. The bold value means result has statistical significance.